-

North America Cosmetic Surgery and Procedure Market (2019 to 2027) - Surging Demand for Energy-Based Liposuction Techniques Presents Opportunities - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "North America Cosmetic Surgery and Procedure Market 2019-2027" report has been added to ResearchAndMarkets.com's offering.

According to the publisher, North America's cosmetic surgery and procedure market is anticipated to witness a CAGR of 5.78% in the estimated period 2019-2027.

The United States and Canada together constitute the North American market. Nearly 18 million people in the United States underwent cosmetic surgical and minimally invasive procedures in 2018, states the ASPS. There has been a rise in the number of procedures in recent years, with over a quarter more million procedures performed in 2018 than 2017. While cosmetic surgical procedures focus on enhancing one's features, plastic surgery is a reconstructive procedure used for patients that have sustained injury or damage due to burns, disease or trauma.

In addition, rising beauty consciousness owing to growing social media influence has raised the demand for procedures such as skin resurfacing, hair removal, and lipoplasty, among others. Non-surgical skin tightening witnessed a major slump of 58% from 2015 to 2016; this procedure is more common among the elderly population group and those desiring to remain more socially active. The middle-aged populace, between 35 to 50 years of age, prefer opting for skin tightening and rejuvenation as preventive measures. The aforementioned statistics indicate the myriad opportunities the US offers for the cosmetic surgery and procedure market's growth.

The prominent companies in the cosmetic surgery and procedure market include Alma Lasers (Acquired By Shanghai Fosun Pharmaceutical (Group) Co Ltd), Lumenis Ltd. (acquired by Xio), Sientra Inc, JOHNSON AND JOHNSON, Candela Corp (Formerly Syneron Medical Ltd), Galderma (Acquired By EQT AB), Ipsen Pharma, and Bausch Health (Formerly VALEANT).

Key Topics Covered:

1. North America Cosmetic Surgery and Procedure Market - Summary

2. Industry Outlook

2.1. Market Definition

2.2. Porter's Five Forces Analysis

2.2.1. Threat of New Entry

2.2.2. Threat of Substitution

2.2.3. Buyer's Power

2.2.4. Supplier's Power

2.2.5. Competitive Rivalry

2.3. Key Insights

2.4. Value Chain Analysis

2.5. Regulatory Framework

2.6. Market Attractiveness Index

2.7. Market Drivers

2.7.1. Increasing Awareness Regarding the Process and Importance of Aesthetic Treatments

2.7.2. Rise in Disposable Income

2.7.3. Growing Aging Population

2.8. Market Restraints

2.8.1. Side-Effects Associated With Breast Implants

2.8.2. Availability of Substitute Treatments

2.8.3. Increase in Explant Procedures

2.9. Market Opportunities

2.9.1. Increase in the Number of Cosmetic Surgeries

2.9.2. Surging Demand for Energy-Based Liposuction Techniques

2.10. Market Challenges

2.10.1. Reimbursement Issue

2.10.2. High Cost of Aesthetic Treatment

3. Cosmetic Surgery and Procedure Market Outlook - by Type

3.1. Surgical

3.1.1. Breast Augmentation

3.1.2. Liposuction

3.1.3. Eyelid Surgery

3.1.4. Tummy Tuck

3.1.5. Breast Lift

3.1.6. Other Surgical Types

3.2. Non-Surgical

3.2.1. Botulinum Toxin

3.2.2. Dermal Fillers

3.2.3. Laser Hair Removal

3.2.4. Chemical Peel

3.2.5. Microdermabrasion

3.2.6. Photo-Rejuvenation

3.2.7. Other Non-Surgical Types

4. Cosmetic Surgery and Procedure Market - North America

4.1. Country Analysis

4.1.1. the United States

4.1.2. Canada

5. Company Profiles

5.1. Candela Corp (Formerly Syneron Medical Ltd)

5.2. Sinclair Pharma

5.3. Cutera

5.4. Galderma (Acquired by Eqt)

5.5. Cynosure Inc

5.6. Sientra Inc

5.7. Allergan Inc

5.8. Nestle

5.9. Ipsen

5.10. Alma Lasers Inc. (Acquired by Fosun Pharma)

5.11. Johnson & Johnson Services

5.12. Bausch Health Companies Inc. (Formerly Valeant Pharmaceuticals)

5.13. Lumenis

5.14. Merz Pharma

6. Research Methodology & Scope

6.1. Research Scope & Deliverables

6.1.1. Objectives of Study

6.1.2. Scope of Study

6.2. Sources of Data

6.2.1. Primary Data Sources

6.2.2. Secondary Data Sources

6.3. Research Methodology

6.3.1. Evaluation of Proposed Market

6.3.2. Identification of Data Sources

6.3.3. Assessment of Market Determinants

6.3.4. Data Collection

6.3.5. Data Validation & Analysis

For more information about this report visit https://www.researchandmarkets.com/r/ozqs0t

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Research and Markets


Release Versions

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

More News From Research and Markets

Tendinopathy Industry Assessment 2025-2035: A Global and Regional Analysis with Focus on Treatment - Innovative Drug Delivery Technologies Transform Tendinopathy Therapy - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Tendinopathy Market - A Global and Regional Analysis: Focus on Treatment and Region - Analysis and Forecast, 2025-2035" has been added to ResearchAndMarkets.com's offering. The global tendinopathy market is experiencing notable expansion, driven by the increasing prevalence of musculoskeletal disorders, heightened awareness about the condition, and advancements in pharmacological, regenerative, and biologic therapies. As the incidence of tendinopathy continues to r...

Pediatric Interventional Cardiology Market & Competitive Landscape of 2025: Recent Developments, Strategies, Sustainability Benchmarking, Product Analysis, Key Persons and Revenue - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Competitive Landscape of Pediatric Interventional Cardiology Market by Recent Developments, Strategies, Sustainability Benchmarking, Product Analysis, Key Persons and Revenue" has been added to ResearchAndMarkets.com's offering. The Pediatric Interventional Cardiology Market is projected to reach US$ 4.34 billion by 2033, up from US$ 2.42 billion in 2024, reflecting a compound annual growth rate (CAGR) of 6.68% from 2025 to 2033. This growth is driven primarily by...

Malaysia Cement Market Size & Forecast by Value and Volume Across 80+ Market Segments, 2025-2029 - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Malaysia Cement Industry Market Size & Forecast by Value and Volume Across 80+ Market Segments by Cement Products, Distribution Channel, Market Share, Import - Export, End Markets - Databook Q2 2025 Update" has been added to ResearchAndMarkets.com's offering. The report delivers a rich, forward-looking analysis of the cement industry, examining market size, pricing dynamics, production, and consumption, as well as segment performance from 2020 to 2029. It inclu...
Back to Newsroom